Macroglobulinemia: Difference between revisions

Jump to navigation Jump to search
(Removing all content from page)
 
No edit summary
Line 1: Line 1:
{{Infobox_Disease |
  Name          = {{PAGENAME}} |
  Image          = |
  Caption        = |
  DiseasesDB    = |
  ICD10          = |
  ICD9          = {{ICD9|273.3}} |
  ICDO          = |
  OMIM          = |
  MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
  MeshID        = D008258 |
}}
'''Macroglobulinemia''' is the presence of increased levels of [[macroglobulin]]s in the circulating [[blood]].
A plasma cell [[dyscrasia]] resembling [[leukemia]] with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an [[immunoglobulin M]] monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 28th ed)


==See also==
* [[Waldenström macroglobulinemia]]
[[Category:Hematology]]
[[sv:Makroglobulinemi]]

Revision as of 16:27, 9 January 2009

Macroglobulinemia
ICD-9 273.3
MeSH D008258

Macroglobulinemia is the presence of increased levels of macroglobulins in the circulating blood. A plasma cell dyscrasia resembling leukemia with cells of lymphocytic, plasmacytic, or intermediate morphology, which secrete an immunoglobulin M monoclonal component. There is diffuse infiltration of bone marrow and also, in many cases, of the spleen, liver, or lymph nodes. The circulating macroglobulin produces symptoms of hyperviscosity syndrome: weakness, fatigue, bleeding disorders, and visual disturbances. Peak incidence is in the sixth and seventh decades. (Dorland, 28th ed)

See also

sv:Makroglobulinemi